Healthcare -
Biotechnology - NASDAQ - US
$ 246.27
-1.16 %
$ 31.8 B
Market Cap
-94.0
P/E
ALNY - NET INCOME
Net Income ALNY - Alnylam Pharmaceuticals, Inc.
-440 M
LAST VALUE
28.15%
2 YEAR CAGR
10.38%
5 YEAR CAGR
-17.31%
10 YEAR CAGR